Biblio

Export 166 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
H. - W. Klafki, Hafermann, H., Bauer, C., Haussmann, U., Kraus, I., Schuchhardt, J., Muck, S., Scherbaum, N., and Wiltfang, J., “Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort.”, J Alzheimers Dis, vol. 54, no. 2, pp. 691-705, 2016.
M. Kleinschmidt, Schoenfeld, R., Göttlich, C., Bittner, D., Metzner, J. Erich, Leplow, B., and Demuth, H. - U., “Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.”, J Alzheimers Dis, vol. 50, no. 1, pp. 111-26, 2016.
S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., “Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.”, J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
M. Kobayashi, Yamada, Y., Shinkawa, K., Nemoto, M., Nemoto, K., and Arai, T., “Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1075-1089, 2022.
A. Kobro-Flatmoen, Hormann, T. Meier, and Gouras, G., “Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 2, pp. 719-733, 2023.
G. Koch, Di Lorenzo, F., Del Olmo, M. Fernandez, Bonní, S., Ponzo, V., Caltagirone, C., Bozzali, M., and Martorana, A., “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
A. Tom Kodamullil, Iyappan, A., Karki, R., Madan, S., Younesi, E., and Hofmann-Apitius, M., “Of Mice and Men: Comparative Analysis of Neuro-Inflammatory Mechanisms in Human and Mouse Using Cause-and-Effect Models.”, J Alzheimers Dis, vol. 59, no. 3, pp. 1045-1055, 2017.
I. V. Kohler, Kämpfen, F., Bandawe, C., and Kohler, H. - P., “Cognition and Cognitive Changes in a Low-Income Sub-Saharan African Aging Population.”, J Alzheimers Dis, vol. 95, no. 1, pp. 195-212, 2023.
A. M. Koivisto, Kurki, M. I., Alafuzoff, I., Sutela, A., Rummukainen, J., Savolainen, S., Vanninen, R., Jääskeläinen, J. E., Soininen, H., and Leinonen, V., “High Risk of Dementia in Ventricular Enlargement with Normal Pressure Hydrocephalus Related Symptoms1.”, J Alzheimers Dis, vol. 52, no. 2, pp. 497-507, 2016.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., “Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
M. Kolarova, Sengupta, U., Bartos, A., Ricny, J., and Kayed, R., “Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls.”, J Alzheimers Dis, vol. 58, no. 2, pp. 471-478, 2017.
T. Kondo, Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S. - I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W. L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., and Inoue, H., “Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.”, Cell Stem Cell, vol. 12, no. 4, pp. 487-96, 2013.
K. Konishi, Joober, R., Poirier, J., MacDonald, K., Chakravarty, M., Patel, R., Breitner, J., and Bohbot, V. D., “Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1493-1507, 2018.
D. Kontaxopoulou, Beratis, I. N., Fragkiadaki, S., Pavlou, D., Andronas, N., Yannis, G., Economou, A., Papanicolaou, A. C., and Papageorgiou, S. G., “Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 2, pp. 617-627, 2018.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S., “Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
A. Koppara, Wolfsgruber, S., Kleineidam, L., Schmidtke, K., Frölich, L., Kurz, A., Schulz, S., Hampel, H., Heuser, I., Peters, O., Reischies, F. M., Jahn, H., Luckhaus, C., Hüll, M., Gertz, H. - J., Schröder, J., Pantel, J., Rienhoff, O., Rüther, E., Henn, F., Wiltfang, J., Maier, W., Jessen, F., Kornhuber, J., and Wagner, M., “The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 547-60, 2016.
A. D. Korczyn, “Dementia in the COVID-19 Period.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1071-1072, 2020.
L. E. Korthauer, Awe, E., Frahmand, M., and Driscoll, I., “Genetic Risk for Age-Related Cognitive Impairment Does Not Predict Cognitive Performance in Middle Age.”, J Alzheimers Dis, vol. 64, no. 2, pp. 459-471, 2018.
K. Kostev, Gessler, N., Wohlmuth, P., Arnold, D., Bein, B., Bohlken, J., Herrlinger, K., Jacob, L., Koyanagi, A., Nowak, L., Smith, L., Wesseler, C., Sheikhzadeh, S., and Wollmer, M. Axel, “Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.”, J Alzheimers Dis, vol. 91, no. 2, pp. 719-726, 2023.
K. Kostev, Hadji, P., and Jacob, L., “Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany.”, J Alzheimers Dis, vol. 65, no. 2, pp. 401-407, 2018.
R. Kotani, Urano, Y., Sugimoto, H., and Noguchi, N., “Decrease of Amyloid-β Levels by Curcumin Derivative via Modulation of Amyloid-β Protein Precursor Trafficking.”, J Alzheimers Dis, vol. 56, no. 2, pp. 529-542, 2017.
I. Koychev, Jansen, K., Dette, A., Shi, L., and Holling, H., “Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.”, J Alzheimers Dis, vol. 79, no. 1, pp. 177-195, 2021.
I. Koychev, Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B., Sahakian, B. J., Rowe, J. B., Thomas, A., Rochester, L., Ffytche, D., Howard, R., Zetterberg, H., MacKay, C., and Lovestone, S., “PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
I. Koychev, Galna, B., Zetterberg, H., Lawson, J., Zamboni, G., Ridha, B. H., Rowe, J. B., Thomas, A., Howard, R., Malhotra, P., Ritchie, C., Lovestone, S., and Rochester, L., “Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
B. Kramarz, Huntley, R. P., Rodríguez-López, M., Roncaglia, P., Saverimuttu, S. C. C., Parkinson, H., Bandopadhyay, R., Martin, M. - J., Orchard, S., Hooper, N. M., Brough, D., and Lovering, R. C., “Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1417-1435, 2020.

Pages